Cancer
622 results
101 - 200- dong quai
- ospemifene
- durvalumab
- erlotinib
- lapatinib
- exemestane
- ribociclib
- trastuzumab/hyaluronidase
- trastuzumab
- palbociclib
- estrogens, conjugated
- cetuximab
- diethylstilbestrol
- anastrozole
- ziv-aflibercept
- ado-trastuzumab
- trifluridine/tipiracil
- dolasetron
- flutamide
- vinorelbine
- clofarabine
- rucaparib
- neratinib
- cyproterone
- gallium nitrate
- sipuleucel
- lycopene
- pertuzumab/trastuzumab/hyaluronidase
- buserelin
- tucatinib
- tisotumab vedotin
- bicalutamide
- toremifene
- abiraterone
- vandetanib
- soy
- enfortumab vedotin
- carmustine
- gefitinib
- niraparib
- ramucirumab
- cabazitaxel
- trametinib
- capecitabine
- epiRUBicin
- fluorouracil
- fulvestrant
- hydroxyprogesterone
- pembrolizumab
- levothyroxine
- alpelisib
- lurbinectedin
- nilutamide
- palonosetron
- cabozantinib
- regorafenib
- ceritinib
- necitumumab
- brigatinib
- prasterone
- lorlatinib
- aminoglutethimide
- letrozole
- leuprolide
- CISplatin
- estradiol/progesterone
- alectinib
- olaparib
- estramustine
- mitoMYcin
- crizotinib
- dabrafenib
- granisetron
- triptorelin
- fam-trastuzumab deruxtecan
- rolapitant
- mitoXANTRONE
- pamidronate
- pilocarpine (systemic)†
- streptozocin